Fact sheet: Janus Gbl Life Sci

Fund information

Fund name
Janus Global Life Sciences A Acc USD
Fund company manager
Janus Capital Funds
Fund type
SIB
Fund manager(s)
Andrew R Acker
since 01/05/2007
Ethan Lovell
since 12/01/2016
Fund objective
This global health care fund seeks consistent returns by investing in companies addressing unmet medical needs or making the health care system more efficient. We balance the portfolio across pharmaceuticals, biotechnology and services/devices sub-sectors in an effort to achieve similar or lower volatility relative to our peers.
Benchmark
MSCI World Healthcare
Investment style
None
Investment method
Shares

Performance snapshot

Sector
Fund
Sector
Fund
Sector
Fund

Quick stats

1 Year return

15.3 %

1 Year rank in sector

11/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 1.9 b

FE Risk score

163

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    77.39%
  • UK
    7.73%
  • France
    4.18%
  • Switzerland
    3.71%
  • Japan
    2.05%
  • Biotechnology/Medical
    38.69%
  • Pharmaceuticals
    27.74%
  • Healthcare & Medical Products
    15.99%
  • Health Care
    13.31%
  • Hospital
    2.39%
  • US Equities
    76.88%
  • International Equities
    21.74%
  • Cash & Cash Equivalents
    0.87%
  • Convertibles
    0.42%
  • Other International Equities
    0.09%

Performance vs. Sector

Sector
Fund
Sector
Fund
Sector
Fund

Cumulative performance

1m6m1y3y5y
Fund-1.9 %4.32 %15.3 %11.72 %121.67 %
Sector-2.72 %3.32 %11.23 %12.3 %97.73 %
Rank within sector11 / 3015 / 3011 / 2911 / 265 / 22
Quartile th2 nd2 nd2 nd2 nd1 st

Calendar performance

YTD-20172016201520142013
Fund18.69 %-13.79 %5.69 %32.75 %52.45 %
Sector13.59 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector9 / 2919 / 2918 / 2613 / 238 / 22
Quartile th2 nd3 rd3 rd3 rd2 nd

Risk statistics

Alpha-0.15
Beta1.03
Sharpe0.05
Volatility16.44
Tracking error4.92
Information ratio-0.04
R-Squared0.91

Price movement

52 week high31.01
52 week low24.75
Current bid price0
Current offer price0
Current mid price29.46

Holdings by region

  • 77.39% USA
  • 7.73% UK
  • 4.18% France
  • 3.71% Switzerland
  • 2.05% Japan
  • 1.77% Germany
  • 1.37% Denmark
  • 0.87% Money Market
  • 0.5% Belgium
  • 0.31% Hungary

Holdings by sector

  • 38.69% Biotechnology/Medical
  • 27.74% Pharmaceuticals
  • 15.99% Healthcare & Medical Products
  • 13.31% Health Care
  • 2.39% Hospital
  • 1.47% Cash & Cash Equivalents
  • 0.41% Convertibles

Holdings by asset type

  • 76.88% US Equities
  • 21.74% International Equities
  • 0.87% Cash & Cash Equivalents
  • 0.42% Convertibles
  • 0.09% Other International Equities

Individual holdings

  • 3.4% LILLY (ELI) & CO
  • 3.2% AETNA INC NEW
  • 3.2% SANOFI
  • 3.1% ASTRAZENECA PLC
  • 2.8% SHIRE PLC
  • 2.4% CELGENE CORP
  • 2.4% HUMANA INC
  • 2.2% BIOGEN INC
  • 2.1% NOVARTIS AG
  • 2.1% REGENERON PHARMACEUTICALS INC